Skip to main content

Advertisement

SpringerLink
Log in

What Is the Impact of Overactive Bladder Symptoms on Female Sexual Function?

  • Overactive Bladder (U Lee, Section Editor)
  • Published:
Current Bladder Dysfunction Reports Aims and scope Submit manuscript

Abstract

Overactive bladder (OAB) and urgency urinary incontinence (UUI) are prevalent disorders which negatively impact not only women’s overall quality of life but also their sexual function. OAB and UUI have been associated with decreases in female sexual satisfaction, desire, arousal, lubrication, and orgasm as well as an increase in sexual pain (Salonia et al. Eur Urol. 45:642, 2004). Successful treatment of OAB with first-, second-, and third-line treatments have been shown to improve overall quality of life and female sexual function scores.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: •• Of major importance

  1. Thom DH, Nygaard IE, Calhoun EA. Urologic diseases in America project: urinary incontinence in women-national trends in hospitalizations, office visits, treatment and economic impact. J Urol. 2005;173:1295.

    Article  PubMed  Google Scholar 

  2. Vinsnes AG, Hunskaar S. Distress associated with urinary incontinence, as measured by a visual analogue scale. Scand J Caring Sci. 1991;5:57.

    Article  CAS  PubMed  Google Scholar 

  3. Wyman JF, Harkins SW, Choi SC, et al. Psychosocial impact of urinary incontinence in women. Obstet Gynecol. 1987;70:378.

    CAS  PubMed  Google Scholar 

  4. van der Vaart CH, de Leeuw JR, Roovers JP, et al. The effect of urinary incontinence and overactive bladder symptoms on quality of life in young women. BJU Int. 2002;90:544.

    Article  PubMed  Google Scholar 

  5. Walters MD, Taylor S, Schoenfeld LS. Psychosexual study of women with detrusor instability. Obstet Gynecol. 1990;75:22.

    CAS  PubMed  Google Scholar 

  6. Coyne KS, Sexton CC, Thompson C, et al. The impact of OAB on sexual health in men and women: results from EpiLUTS. J Sex Med. 2011;8:1603. Cross-sectional population-based survey of 14,440 men and women examining the effect of OAB on sexual health.

    Article  PubMed  Google Scholar 

  7. Su CC, Sun BY, Jiann BP. Association of urinary incontinence and sexual function in women. Int J Urol. 2015;22:109.

    Article  PubMed  Google Scholar 

  8. Handa VL, Harvey L, Cundiff GW, et al. Sexual function among women with urinary incontinence and pelvic organ prolapse. Am J Obstet Gynecol. 2004;191:751.

    Article  PubMed  Google Scholar 

  9. Gordon D, Groutz A, Sinai T, et al. Sexual function in women attending a urogynecology clinic. Int Urogynecol J Pelvic Floor Dysfunct. 1999;10:325.

    Article  CAS  PubMed  Google Scholar 

  10. Yip SK, Chan A, Pang S, et al. The impact of urodynamic stress incontinence and detrusor overactivity on marital relationship and sexual function. Am J Obstet Gynecol. 2003;188:1244.

    Article  PubMed  Google Scholar 

  11. Oh SJ, Ku JH, Choo MS, et al. Health-related quality of life and sexual function in women with stress urinary incontinence and overactive bladder. Int J Urol. 2008;15:62.

    Article  PubMed  Google Scholar 

  12. Cohen BL, Barboglio P, Gousse A. The impact of lower urinary tract symptoms and urinary incontinence on female sexual dysfunction using a validated instrument. J Sex Med. 2008;5:1418.

    Article  PubMed  Google Scholar 

  13. Salonia A, Zanni G, Nappi RE, et al. Sexual dysfunction is common in women with lower urinary tract symptoms and urinary incontinence: results of a cross-sectional study. Eur Urol. 2004;45:642.

    Article  PubMed  Google Scholar 

  14. Sacomori C, Cardoso FL. Predictors of improvement in sexual function of women with urinary incontinence after treatment with pelvic floor exercises: a secondary analysis. J Sex Med. 2015;12:746.

    Article  PubMed  Google Scholar 

  15. Sand PK, Goldberg RP, Dmochowski RR, et al. The impact of the overactive bladder syndrome on sexual function: a preliminary report from the Multicenter Assessment of Transdermal Therapy in Overactive Bladder with Oxybutynin trial. Am J Obstet Gynecol. 2006;195:1730.

    Article  PubMed  Google Scholar 

  16. Rogers RG, Bachmann G, Scarpero H, et al. Effects of tolterodine ER on patient-reported outcomes in sexually active women with overactive bladder and urgency urinary incontinence. Curr Med Res Opin. 2009;25:2159.

    Article  CAS  PubMed  Google Scholar 

  17. Rogers RG, Omotosho T, Bachmann G, et al. Continued symptom improvement in sexually active women with overactive bladder and urgency urinary incontinence treated with tolterodine ER for 6 months. Int Urogynecol J Pelvic Floor Dysfunct. 2009;20:381.

    Article  PubMed  Google Scholar 

  18. Hajebrahimi S, Azaripour A, Sadeghi-Bazargani H. Tolterodine immediate release improves sexual function in women with overactive bladder. J Sex Med. 2008;5:2880.

    Article  PubMed  Google Scholar 

  19. Jha S: Impact of treatment of overactive bladder with anticholinergics on sexual function. Arch Gynecol Obstet 2015; 3828–5

  20. Pauls RN, Marinkovic SP, Silva WA, et al. Effects of sacral neuromodulation on female sexual function. Int Urogynecol J Pelvic Floor Dysfunct. 2007;18:391.

    Article  PubMed  Google Scholar 

  21. Signorello D, Seitz CC, Berner L, et al. Impact of sacral neuromodulation on female sexual function and his correlation with clinical outcome and quality of life indexes: a monocentric experience. J Sex Med. 2011;8:1147.

    Article  PubMed  Google Scholar 

  22. Yih JM, Killinger KA, Boura JA, et al. Changes in sexual functioning in women after neuromodulation for voiding dysfunction. J Sex Med. 2013;10:2477.

    Article  PubMed  Google Scholar 

  23. Lombardi G, Finazzi Agro E, Del Popolo G: Sacral neuromodulation and female sexuality. Int Urogynecol J 2015; 2708.

  24. Giannantoni A, Proietti S, Giusti G et al.: OnabotulinumtoxinA intradetrusorial injections improve sexual function in female patients affected by multiple sclerosis: preliminary results. World J Urol 2015; 1578.

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University Cleveland, Cleveland, OH, USA

    Courtenay K. Moore

  2. Female Pelvic Medicine and Reconstructive Surgery Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA

    Courtenay K. Moore

Authors
  1. Courtenay K. Moore
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Courtenay K. Moore.

Ethics declarations

Conflict of Interest

Dr. Moore reports other from Allergan, outside the submitted work.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Overactive Bladder

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Moore, C.K. What Is the Impact of Overactive Bladder Symptoms on Female Sexual Function?. Curr Bladder Dysfunct Rep 11, 25–28 (2016). https://doi.org/10.1007/s11884-016-0346-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11884-016-0346-7

Keywords

Search

Navigation